Stryker Revenue

Macroaxis Equity Filters allow users to customize the simple screener criteria below or select from a set of available quick indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations

Revenue Analysis

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of business and is important item when evaluating financial statements of a company. Revenues from a firm's main business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which given company operates.
Stryker 
Revenue 
 = 
Money Received 
Discounts and Returns 
 = 
10.88 B

Distress Driver Correlations

 Stryker Revenues 
Benchmark  Embed   Timeline 

About Revenue

Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Compare to competition
Based on latest financial disclosure Stryker Corporation reported 10.88 B of revenue. This is much higher than that of the sector, and significantly higher than that of Revenue industry, The Revenue for all stocks is over 1000% lower than the firm.
ETFsFundsStocks

Filter other Stocks by Revenue

Revenue Input Range 
Industry  
Click to run this filter
Filter Other Equities
  
Showing first 21 of many similar equities found by Revenue
FMCCT OBBFederal Home Loan Mortgage Corporation
7.68 B
EIPAF PNKEni SpA
57.89 B
AKBIF PNKAkebono Brake Industry Co Ltd
265.17 B
CGUIY PNKCASINO GUICHARD PERR
IVSBY PNKInvestor AB
1.46 B
FNMFO PNKFederal National Mortgage Association
3.88 B
MSADF PNKMSAD Insurance Group Holdings Inc
45.46 B
AHOND PNKKoninklijke Ahold NV
CHYFF PNKCathay Financial Holding Co Ltd
21.23 B
FNMFO PNKFED NATL MTG PFD I
4.93 B
ISRG NMSIntuitive Surgical Inc
2.62 B
BSX NYQBoston Scientific Corporation
8.1 B
COO NYQThe Cooper Companies Inc
1.9 B
DGX NYQQuest Diagnostics Inc
7.5 B
RMD NYQResMed Inc
1.89 B
TFX NYQTeleflex Incorporated
1.83 B
SYK NYQStryker Corporation
10.88 B
STJ NYQSt Jude Medical Inc
5.96 B
VAR NYQVarian Medical Systems Inc
3.22 B
DHRM NCMDehaier Medical Systems Limited
6.4 M
DXCM NMSDexCom Inc
532.9 M
You can backtest this sub-set of assets as a synthetic portfolio or check its risk adjusted returns  
Peer Comparison
Stryker Revenue Comparison
  Revenue 
Benchmark  Embed   Stryker Comparables 
Stryker is rated fifth in revenue category among related companies.
Did you try this?
Run Alpha Finder Now
   

Alpha Finder

Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Hide  View All  Next  Launch Alpha Finder
Return On Equity18.62 %
Return On Asset8.53 %
Profit Margin15.24 %
Operating Margin22.65 %
Current Valuation45.67 B
Shares Outstanding374.45 M
Shares Owned by Insiders8.29 %
Shares Owned by Institutions76.00 %
Number of Shares Shorted6.46 M
Price to Earning25.43 times
Price to Book4.44 times
Price to Sales3.81 times
Revenue10.88 B
Gross Profit6.6 B
EBITDA2.97 B
Net Income1.66 B
Cash and Equivalents3.02 B
Cash per Share8.07 times
Total Debt6.85 B
Debt to Equity0.73 times
Current Ratio2.43 times
Book Value Per Share24.92 times
Cash Flow from Operations1.84 B
Short Ratio5.52 times
One Year High123.55
One Year Low86.68
Earnings Per Share4.39 times
Price to Earnings To Growth1.91 times
Number of Employees27 K
Beta0.54
Market Capitalization41.85 B
Total Asset20.19 B
Retained Earnings8.49 B
Working Capital4.34 B
Current Asset7.37 B
Current Liabilities3.03 B
Z Score3.6